Medicare costs are going up next year
Like most things, Medicare costs are going up next year. Medicare Part A and Part B deductibles will increase, along
Read More
Older Adults
Resources Are Expanding for Older Adults on Their Own
(By Judith Graham for KFF Health News) Jeff Kromrey, 69, will sit down with his daughter the next time she
Read MoreMedicare Spending was 27% More for People who Disenrolled from Medicare Advantage than for Similar People in Traditional Medicare
(By Jeannie Fuglesten Biniek, Alex Cottrill, Nolan Sroczynski, and Tricia Neuman for The Kaiser Family Foundation Published: Dec 06, 2024)
Read MoreMedicaid payments vs. nursing home costs: 5 takeaways
(By Elizabeth Gregerson for Becker’s Hospital Review) Medicaid payment rates given to the average nursing home covered about 82 cents
Read MoreNursing Home Industry Wants Trump To Rescind Staffing Mandate
(By Jordan Rau for KFF Health News) Covid’s rampage through the country’s nursing homes killed more than 172,000 residents and
Read MoreHumana spread Medicare Advantage ‘misinformation,’ Minnesota AG alleges
(Rylee Wilson for Becker’s Hospital Review) Humana misrepresented the providers its Medicare Advantage plans will be in-network with in 2025,
Read MoreHomebound Seniors Living Alone Often Slip Through Health System’s Cracks
(By Judith Graham for KFF Health News) Carolyn Dickens, 76, was sitting at her dining room table, struggling to catch
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(Juliette Cubanski for The Kaiser Family Foundation Published: Nov 19, 2024) The Inflation Reduction Act of 2022 (the Act), signed
Read MoreUS News names top Medicare Advantage, Part D providers for 2025
(By Kelly Gooch for Becker’s Hospital Review) U.S. News & World Report has recognized seven Medicare Advantage and Medicare Part
Read MoreFuture of Medicare drug price negotiations under new administration: 5 things to know
(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More